Sorry psych, no migraine for you

Discussion in 'Lundbeck' started by anonymous, Oct 22, 2019 at 3:33 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Looks like Neurology is the future
     

  2. anonymous

    anonymous Guest

    What a joke! You will have, what, the 4th entry into the market that has to be infused, vs a 3 second at home injection. Then Biohaven comes out with an ORAL VERSION! What you have done is buy time. Psych will continue to struggle selling its 3 me too drugs with nothing new of any significance until their patents expire. At some point, psych will have to be reduced.

    Yep, you have bought yourself some time but you still haven’t got much more security than psych. The fact is , psych will start to diminish. There is still no future here.
     
  3. anonymous

    anonymous Guest

    I don’t want that drug. Have fun launching and selling this in a highly competitive migraine market. And Lilly just got an oral med too. Have fun with that!
     
  4. anonymous

    anonymous Guest

    From JA’s email today, both Neuro and psych may be undergoing a reorganization. Hopefully there will be some type of lay-off connected to it. They have rolled the dice to the tune of $2,000,000,000 on Alder’s headache drug. They will lock horns with the giants of the industry, and a new biotech start up. This is a perfect recipe for disaster. Add on the government’s future regulations for the industry, and it looks even worse. They need to cut psych in half, or replace it altogether with a contract team. Bet the farm on the headache drug.

    Things are changing.
     
  5. anonymous

    anonymous Guest

    Neuro will not have layoffs anytime soon
     
  6. anonymous

    anonymous Guest

    psych has no drugs, it's a contract sales force just entering calls
     
  7. anonymous

    anonymous Guest

    recruiter here... lundbeck psych sales force is looked at as primary care.
     
  8. anonymous

    anonymous Guest

    Really neuro guys and gals??? Really? you are getting excited about the 4th to market drug? You really think you will sell an injection when there are pens available? You really think you can sell an injection vs an oral? And do you really think insurance companies will pay for all 4? If you answered yes to any of those you are suffering from mental illness and need to ask your psych counterpart for a referral. Just ask you psych buddies how insurance is when covering 4th to market me too drugs. Get off your high horses, you will be out of a job just as quickly as the psych boys and girls.
     
  9. anonymous

    anonymous Guest


    Is neuro?
     
  10. anonymous

    anonymous Guest

    I’m pumped. We are all getting raises with Alder paying their reps $140k
     
  11. anonymous

    anonymous Guest

    Alder doesn’t have any reps you idiot.
     
  12. anonymous

    anonymous Guest

    Wow you are all a bunch of complaining babies. Psych vs neuro, neuro vs psych each putting down the other who cares! I’m embarrassed to work with people like this. Is a damn job. Put it in perspective!
     
  13. anonymous

    anonymous Guest

    The key phrase you said was, “it’s a damn job”, and you’re right. There is no “career” here, just temp work. At some point, they will realize that they have wrung out every penny from the psych drugs. Upcoming government regs will make it even worse, and psych will reorganize, significantly. The future going forth will be trying to sell the migraine drug, but they hope the psych drugs will keep them going until then. The U.S. keeps shrinking in terms of its contribution to the company which isn’t good for us. China and elsewhere will become more and more important. They will be forced to make hard decisions about the U.S.

    THe migraine drug will have it tough. It’s takes about 15 seconds to ready and administer a self-injected drug. I know because I use one weekly. So, if the injection is once a month, that’s 45 seconds in total giving 3 injections over 3 months. Compare that to driving to an infusion center, waiting to go back, getting hooked up to an IV, and sitting there for 30 minutes. Or, you could just take a daily pill.

    Food for thought.
     
  14. anonymous

    anonymous Guest

    Every pharma job is a job. The days of a career with one company are over. Either your products aren’t doing well and you’re on the chopping block, or they’re doing really well and you’re at risk of being bought out by someone. So take it for what it is, enjoy the paycheck, work hard and move on to the next one when the time comes. If you want to stay in this industry, it’s something that you have to come to terms with.
     
  15. anonymous

    anonymous Guest


    Just out of curiosity, what is wrong with primary care? Most reps in the industry call on both PCPs and specialists- wherever the business is. For specialty only, territories are huge, access is difficult, etc. So why do people hate calling on primary care? It’s easy!
     
  16. anonymous

    anonymous Guest

    Couldn’t agree more. Some of the territories at Lundbeck are ridiculously huge, while others are tiny. Calling on PC would be great. Don’t care anything about our migraine drug. With 2 orals out soon, why take an infusion.
     
  17. anonymous

    anonymous Guest

     
  18. anonymous

    anonymous Guest

    PCP is demeaning and only for entry level reps.
     
  19. anonymous

    anonymous Guest

     
  20. anonymous

    anonymous Guest

    Summitt thinks they are getting it